2019 Annual Meeting | C123 - Child Neurology: Genetic and Metabolic Testing in Pediatric Epilepsy
Program Materials Program Evaluations
07:00 AM - 07:10 AM EDT | Speaker |
Introduction
James J. Riviello, Jr., MD |
07:10 AM - 07:40 AM EDT | Speaker |
Overview of Genetics in 2018, Especially Next Generation Sequencing
Tristan T. Sands, MD, PhD |
07:40 AM - 08:10 AM EDT | Speaker |
The Diagnostic Approach to Genetic and Metabolic Testing in Epilepsy
Lisa T. Emrick, MD |
08:10 AM - 08:40 AM EDT | Speaker |
Medical and Surgical Implications of Genetic Testing in Epilepsy
James J. Riviello, Jr., MD |
08:40 AM - 09:00 AM EDT | Q&A |
Questions and Answers
|
James J. Riviello, Jr., MD | Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary. |
Lisa T. Emrick, MD | Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH. |
Tristan T. Sands, MD, PhD | No disclosure on file |